- Home
- MNPR vs CPS Comparison
MNPR vs CPS Comparison
Compare MNPR & CPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNPR
- CPS
- Stock Information
- Founded
- MNPR 2014
- CPS 1960
- Country
- MNPR United States
- CPS United States
- Employees
- MNPR N/A
- CPS N/A
- Industry
- MNPR Biotechnology: Pharmaceutical Preparations
- CPS Auto Parts:O.E.M.
- Sector
- MNPR Health Care
- CPS Consumer Discretionary
- Exchange
- MNPR Nasdaq
- CPS Nasdaq
- Market Cap
- MNPR 250.0M
- CPS 250.0M
- IPO Year
- MNPR 2019
- CPS N/A
- Fundamental
- Price
- MNPR $40.25
- CPS $14.73
- Analyst Decision
- MNPR Strong Buy
- CPS
- Analyst Count
- MNPR 4
- CPS 0
- Target Price
- MNPR $43.00
- CPS N/A
- AVG Volume (30 Days)
- MNPR 71.2K
- CPS 247.3K
- Earning Date
- MNPR 03-27-2025
- CPS 02-13-2025
- Dividend Yield
- MNPR N/A
- CPS N/A
- EPS Growth
- MNPR N/A
- CPS N/A
- EPS
- MNPR N/A
- CPS N/A
- Revenue
- MNPR N/A
- CPS $2,730,893,000.00
- Revenue This Year
- MNPR N/A
- CPS $10.95
- Revenue Next Year
- MNPR N/A
- CPS N/A
- P/E Ratio
- MNPR N/A
- CPS N/A
- Revenue Growth
- MNPR N/A
- CPS N/A
- 52 Week Low
- MNPR $1.72
- CPS $11.24
- 52 Week High
- MNPR $54.30
- CPS $19.21
- Technical
- Relative Strength Index (RSI)
- MNPR 49.34
- CPS 48.77
- Support Level
- MNPR $38.80
- CPS $13.85
- Resistance Level
- MNPR $45.60
- CPS $16.21
- Average True Range (ATR)
- MNPR 5.19
- CPS 0.88
- MACD
- MNPR -1.50
- CPS -0.02
- Stochastic Oscillator
- MNPR 9.37
- CPS 56.98
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicin for the treatment of soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
About CPS Cooper-Standard Holdings Inc.
Cooper-Standard Holdings Inc is a supplier of rubber and resin products for the automotive industry. The company produces rubber and plastic sealings, fuel and brake lines, fluid transfer hoses, and anti-vibration systems used by original equipment manufacturers and replacement markets for passenger vehicles and light trucks. The largest customers include Ford, GM, FCA, Peugeot Citroen, and Volkswagen. Cooper Standard generates the majority of its revenue with its sealing systems products such as Fortrex, dynamic and static seals, stainless steel trims, flush glass systems, and variable extrusions.